Orthofix Medical
(NASDAQ) OFIX
Orthofix Medical Financials at a Glance
Market Cap
$469.69M
Revenue (TTM)
$822.31M
Net Income (TTM)
$92.19M
EPS (TTM)
$-2.34
P/E Ratio
-5.00
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$11.55
Volume
3,727
Open
$11.88
Price
$11.55
Volume
3,727
Open
$11.88
Previous Close
$11.70
Daily Range
$11.43 - $11.88
52-Week Range
$10.24 - $17.00
Dividend
$0.00
Beta (Volatility)
1.00 (Average)
Price
$11.55
Volume
3,727
Open
$11.88
Previous Close
$11.70
Daily Range
$11.43 - $11.88
52-Week Range
$10.24 - $17.00
OFIX News
Why Orthofix Shares Got Crushed
OFIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Orthofix Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,605
CEO
Massimo Calafiore, MBA
Website
www.orthofix.comHeadquarters
Lewisville, TX 75056, US
OFIX Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-8%
Net Income Margin
-11%
Return on Equity
-19%
Return on Capital
-10%
Return on Assets
-11%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$469.69M
Shares Outstanding
40.14M
Volume
3.73K
Short Interest
0.00%
Avg. Volume
252.45K
Financials (TTM)
Gross Profit
$551.71M
Operating Income
$68.47M
EBITDA
$22.35M
Operating Cash Flow
$33.35M
Capital Expenditure
$34.63M
Free Cash Flow
$1.28M
Cash & ST Invst.
$82.03M
Total Debt
$229.26M
Orthofix Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$219.91M
+2.0%
Gross Profit
$142.03M
-4.6%
Gross Margin
64.59%
N/A
Market Cap
$469.69M
N/A
Market Cap/Employee
$290.65K
N/A
Employees
1,616
N/A
Net Income
$2.22M
+92.4%
EBITDA
$91.52M
+629.7%
Quarterly Fundamentals
Net Cash
$147.24M
-52.8%
Accounts Receivable
$135.75M
+0.8%
Inventory
$172.32M
-9.0%
Long Term Debt
$225.28M
+28.8%
Short Term Debt
$3.98M
-16.6%
Return on Assets
-10.84%
N/A
Return on Invested Capital
-10.07%
N/A
Free Cash Flow
$17.61M
+15.9%
Operating Cash Flow
$28.48M
+20.0%